Union Pacific on Track for Lowest Close Since November 2023 — Data Talk
Union Pacific Corporation (UNP) is currently at $228.98, down $2.28 or 0.99%
--Would be lowest close since Nov. 30, 2023, when it closed at $225.27
--Currently down seven of the past eight days
--Currently down six consecutive days; down 4.9% over this period
--Longest losing streak since March 13, 2023, when it fell for seven straight trading days
--Worst six day stretch since the six days ending Sept. 8, 2023, when it fell 4.98%
--Down 6.89% month-to-date
--Down 6.77% year-to-date
--Down 17.24% from its all-time closing high of $276.69 on March 30, 2022
--Up 13.36% from 52 weeks ago (April 19, 2023), when it closed at $202.00
--Down 10.87% from its 52-week closing high of $256.91 on Feb. 23, 2024
--Up 19.57% from its 52-week closing low of $191.50 on April 26, 2023
--Traded as low as $227.87; lowest intraday level since Dec. 1, 2023, when it hit $226.24
--Down 1.47% at today's intraday low
All data as of 11:07:49 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 17, 2024 11:24 ET (15:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track